These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 25487646

  • 1. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
    Vongpromek R, Bos S, Ten Kate GJ, Yahya R, Verhoeven AJ, de Feyter PJ, Kronenberg F, Roeters van Lennep JE, Sijbrands EJ, Mulder MT.
    J Intern Med; 2015 Aug; 278(2):166-73. PubMed ID: 25487646
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia.
    Vuorio A, Watts GF, Kovanen PT.
    Atherosclerosis; 2019 Feb; 281():25-30. PubMed ID: 30616181
    [Abstract] [Full Text] [Related]

  • 3. Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.
    Ten Kate GR, Bos S, Dedic A, Neefjes LA, Kurata A, Langendonk JG, Liem A, Moelker A, Krestin GP, de Feyter PJ, Roeters van Lennep JE, Nieman K, Sijbrands EJ.
    J Am Coll Cardiol; 2015 Dec 22; 66(24):2687-2695. PubMed ID: 26700830
    [Abstract] [Full Text] [Related]

  • 4. Coronary artery calcification correlates with the presence and severity of valve calcification.
    Koulaouzidis G, Nicoll R, MacArthur T, Jenkins PJ, Henein MY.
    Int J Cardiol; 2013 Oct 15; 168(6):5263-6. PubMed ID: 23993324
    [Abstract] [Full Text] [Related]

  • 5. Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.
    Marrero N, Jha K, Razavi AC, Boakye E, Anchouche K, Dzaye O, Budoff MJ, Tsai MY, Shah SJ, Rotter JI, Guo X, Yao J, Blumenthal RS, Thanassoulis G, Post WS, Blaha MJ, Whelton SP.
    Circ Cardiovasc Imaging; 2024 Jun 15; 17(6):e016372. PubMed ID: 38889215
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein(a) is robustly associated with aortic valve calcium.
    Kaiser Y, Singh SS, Zheng KH, Verbeek R, Kavousi M, Pinto SJ, Vernooij MW, Sijbrands EJG, Boekholdt SM, de Rijke YB, Stroes ESG, Bos D.
    Heart; 2021 Sep 15; 107(17):1422-1428. PubMed ID: 33963048
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis.
    Cao J, Steffen BT, Budoff M, Post WS, Thanassoulis G, Kestenbaum B, McConnell JP, Warnick R, Guan W, Tsai MY.
    Arterioscler Thromb Vasc Biol; 2016 May 15; 36(5):1003-9. PubMed ID: 26941019
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification.
    Kaiser Y, van der Toorn JE, Singh SS, Zheng KH, Kavousi M, Sijbrands EJG, Stroes ESG, Vernooij MW, de Rijke YB, Boekholdt SM, Bos D.
    Eur Heart J; 2022 Oct 14; 43(39):3960-3967. PubMed ID: 35869873
    [Abstract] [Full Text] [Related]

  • 9. Relation of aortic valve calcium to chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).
    Guerraty MA, Chai B, Hsu JY, Ojo AO, Gao Y, Yang W, Keane MG, Budoff MJ, Mohler ER, CRIC Study Investigators.
    Am J Cardiol; 2015 May 01; 115(9):1281-6. PubMed ID: 25791240
    [Abstract] [Full Text] [Related]

  • 10. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
    Morita H, Takeda Y, Fujita S, Okamoto Y, Sakane K, Teramoto K, Ozeki M, Tasaki R, Kizawa S, Sohmiya K, Hoshiga M, Ishizaka N.
    J Atheroscler Thromb; 2015 May 01; 22(12):1338-46. PubMed ID: 26279337
    [Abstract] [Full Text] [Related]

  • 11. Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
    Vongpromek R, Bos S, Ten Kate GR, Bujo H, Jiang M, Nieman K, Schneider W, Roeters van Lennep JE, Verhoeven AJM, Sijbrands EJG, Mulder MT.
    Atherosclerosis; 2017 Oct 01; 265():299-304. PubMed ID: 28637586
    [Abstract] [Full Text] [Related]

  • 12. PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
    Alonso R, Mata P, Muñiz O, Fuentes-Jimenez F, Díaz JL, Zambón D, Tomás M, Martin C, Moyon T, Croyal M, Thedrez A, Lambert G.
    Atherosclerosis; 2016 Nov 01; 254():249-253. PubMed ID: 27594539
    [Abstract] [Full Text] [Related]

  • 13. Aortic root, not valve, calcification correlates with coronary artery calcification in patients with severe aortic stenosis: A two-center study.
    Henein M, Hällgren P, Holmgren A, Sörensen K, Ibrahimi P, Kofoed KF, Larsen LH, Hassager C.
    Atherosclerosis; 2015 Dec 01; 243(2):631-7. PubMed ID: 26551591
    [Abstract] [Full Text] [Related]

  • 14. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E, Giusti B, Cordisco A, Gori AM, Sereni A, Sofi F, Mori F, Colonna S, Fugazzaro MP, Pepe G, Nistri S, Marcucci R.
    Intern Emerg Med; 2019 Jan 01; 14(1):45-50. PubMed ID: 30099661
    [Abstract] [Full Text] [Related]

  • 15. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study.
    Tastet L, Capoulade R, Clavel MA, Larose É, Shen M, Dahou A, Arsenault M, Mathieu P, Bédard É, Dumesnil JG, Tremblay A, Bossé Y, Després JP, Pibarot P.
    Eur Heart J Cardiovasc Imaging; 2017 Jan 01; 18(1):70-78. PubMed ID: 26896413
    [Abstract] [Full Text] [Related]

  • 16. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    Zheng KH, Tsimikas S, Pawade T, Kroon J, Jenkins WSA, Doris MK, White AC, Timmers NKLM, Hjortnaes J, Rogers MA, Aikawa E, Arsenault BJ, Witztum JL, Newby DE, Koschinsky ML, Fayad ZA, Stroes ESG, Boekholdt SM, Dweck MR.
    J Am Coll Cardiol; 2019 May 07; 73(17):2150-2162. PubMed ID: 31047003
    [Abstract] [Full Text] [Related]

  • 17. [Aortic valve calcification prevalence and association with coronary risk factors and atherosclerosis in Mexican population].
    Acuña-Valerio J, Rodas-Díaz MA, Macias-Garrido E, Posadas-Sánchez R, Juárez-Rojas JG, Medina-Urrutia AX, Cardoso-Saldaña GC, Joge-Galarza E, Torres-Tamayo M, Vargas-Alarcón G, Posadas-Romero C.
    Arch Cardiol Mex; 2017 May 07; 87(2):108-115. PubMed ID: 27389533
    [Abstract] [Full Text] [Related]

  • 18. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
    Kamstrup PR, Tybjærg-Hansen A, Nordestgaard BG.
    J Am Coll Cardiol; 2014 Feb 11; 63(5):470-7. PubMed ID: 24161338
    [Abstract] [Full Text] [Related]

  • 19. Association between pentraxin 3 levels and aortic valve calcification.
    Norimatsu K, Miura S, Suematsu Y, Shiga Y, Miyase Y, Nakamura A, Zhang B, Saku K.
    J Cardiol; 2016 Jul 11; 68(1):76-82. PubMed ID: 26388550
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.